NIH/National Institute of Allergy and Infectious Diseases

Diseases, Conditions, Syndromes

Experimental Ebola antibody protects monkeys

Scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and colleagues have discovered that a single monoclonal antibody—a protein that attacks viruses—isolated ...

Diseases, Conditions, Syndromes

Experts highlight Ebola vaccine progress and suggest next steps

Despite promising advances, important scientific questions remain unanswered in the effort to develop a safe and effective Ebola vaccine, according to members of an international Ebola research consortium. In a Viewpoint ...

Diseases, Conditions, Syndromes

Marburg virus vaccine shows promising results in first-in-human study

A newly published paper in The Lancet shows that an experimental vaccine against Marburg virus (MARV) was safe and induced an immune response in a small, first-in-human clinical trial. The vaccine, developed by researchers ...

page 9 from 40